Catherine Hankins

Summary

Affiliation: Joint United Nations Programme on HIV/AIDS
Country: Switzerland

Publications

  1. ncbi Gender, sex, and HIV: how well are we addressing the imbalance?
    Catherine Hankins
    Evidence, Monitoring, and Policy, Joint United Nations Programme on HIV AIDS, 1211 Geneva 27, Switzerland
    Curr Opin HIV AIDS 3:514-20. 2008
  2. ncbi Planning for pre-exposure prophylaxis to prevent HIV transmission: challenges and opportunities
    Susan C Kim
    O Neill Institute for National and Global Health Law, Georgetown University, Washington, DC, USA
    J Int AIDS Soc 13:24. 2010
  3. ncbi Asking the right questions: developing evidence-based strategies for treating HIV in women and children
    Quarraisha Abdool Karim
    Department of Epidemiology, Columbia University, New York, USA
    BMC Public Health 11:388. 2011
  4. ncbi Combination prevention: a deeper understanding of effective HIV prevention
    Catherine A Hankins
    Office of the Deputy Executive Director, Programme Branch, Joint United Nations Programme on HIV AIDS, Geneva, Switzerland
    AIDS 24:S70-80. 2010
  5. ncbi From a vicious circle to a virtuous circle: reinforcing strategies of risk, vulnerability, and impact reduction for HIV prevention
    Catherine Hankins
    Social Mobilisation and Strategic Information Department, UNAIDS-Joint United Nations Programme on HIV/AIDS, CH-1211 Geneva 27, Switzerland
    Lancet 364:1915-6. 2004
  6. ncbi Voluntary medical male circumcision: an introduction to the cost, impact, and challenges of accelerated scaling up
    Catherine Hankins
    Joint United Nations Programme on HIV AIDS, Geneva, Switzerland
    PLoS Med 8:e1001127. 2011
  7. ncbi Towards universal access to HIV prevention, treatment, care, and support: the role of tuberculosis/HIV collaboration
    Alasdair Reid
    Stop TB Department, WHO, Geneva, Switzerland
    Lancet Infect Dis 6:483-95. 2006
  8. ncbi Male circumcision: implications for women as sexual partners and parents
    Catherine Hankins
    Department of Policy, Evidence and Partnerships and Chief Scientific Adviser to UNAIDS, Geneva, Switzerland
    Reprod Health Matters 15:62-7. 2007
  9. ncbi Gender-sensitive reporting in medical research
    Shirin Heidari
    International AIDS Society, Geneva, Switzerland
    J Int AIDS Soc 15:11. 2012
  10. ncbi The potential impact of male circumcision on HIV in Sub-Saharan Africa
    Brian G Williams
    World Health Organization, Stop TB Department, Geneva, Switzerland
    PLoS Med 3:e262. 2006

Detail Information

Publications27

  1. ncbi Gender, sex, and HIV: how well are we addressing the imbalance?
    Catherine Hankins
    Evidence, Monitoring, and Policy, Joint United Nations Programme on HIV AIDS, 1211 Geneva 27, Switzerland
    Curr Opin HIV AIDS 3:514-20. 2008
    ..Heightened interest in sex and gender differences in HIV warrant a review of the status of current understanding of their determinants and progress in addressing them...
  2. ncbi Planning for pre-exposure prophylaxis to prevent HIV transmission: challenges and opportunities
    Susan C Kim
    O Neill Institute for National and Global Health Law, Georgetown University, Washington, DC, USA
    J Int AIDS Soc 13:24. 2010
    ..This paper identifies the key action points that emerged from the Planning for PrEP meeting...
  3. ncbi Asking the right questions: developing evidence-based strategies for treating HIV in women and children
    Quarraisha Abdool Karim
    Department of Epidemiology, Columbia University, New York, USA
    BMC Public Health 11:388. 2011
    ..The guideline's new goals present an opportunity for advancing the women and children's agenda outlined in the Consensus Statement...
  4. ncbi Combination prevention: a deeper understanding of effective HIV prevention
    Catherine A Hankins
    Office of the Deputy Executive Director, Programme Branch, Joint United Nations Programme on HIV AIDS, Geneva, Switzerland
    AIDS 24:S70-80. 2010
    ....
  5. ncbi From a vicious circle to a virtuous circle: reinforcing strategies of risk, vulnerability, and impact reduction for HIV prevention
    Catherine Hankins
    Social Mobilisation and Strategic Information Department, UNAIDS-Joint United Nations Programme on HIV/AIDS, CH-1211 Geneva 27, Switzerland
    Lancet 364:1915-6. 2004
  6. ncbi Voluntary medical male circumcision: an introduction to the cost, impact, and challenges of accelerated scaling up
    Catherine Hankins
    Joint United Nations Programme on HIV AIDS, Geneva, Switzerland
    PLoS Med 8:e1001127. 2011
    ..This collection of articles on determining the cost and impact of VMMC for HIV prevention signposts the way forward to scaling up VMMC service delivery safely and efficiently to reap individual- and population-level benefits...
  7. ncbi Towards universal access to HIV prevention, treatment, care, and support: the role of tuberculosis/HIV collaboration
    Alasdair Reid
    Stop TB Department, WHO, Geneva, Switzerland
    Lancet Infect Dis 6:483-95. 2006
    ....
  8. ncbi Male circumcision: implications for women as sexual partners and parents
    Catherine Hankins
    Department of Policy, Evidence and Partnerships and Chief Scientific Adviser to UNAIDS, Geneva, Switzerland
    Reprod Health Matters 15:62-7. 2007
  9. ncbi Gender-sensitive reporting in medical research
    Shirin Heidari
    International AIDS Society, Geneva, Switzerland
    J Int AIDS Soc 15:11. 2012
    ..Journal editors are also promoters of ethical research and adequate standards of reporting, and requirements for inclusion of gender analyses should be integrated into editorial policies as a matter of urgency...
  10. ncbi The potential impact of male circumcision on HIV in Sub-Saharan Africa
    Brian G Williams
    World Health Organization, Stop TB Department, Geneva, Switzerland
    PLoS Med 3:e262. 2006
    ..We explore the implications of this finding for the promotion of MC as a public health intervention to control HIV in sub-Saharan Africa...
  11. ncbi Expanding research capacity and accelerating AIDS vaccine development in Asia
    Jean Louis Excler
    International AIDS Vaccine Initiative IAVI, Geneva, Switzerland
    Southeast Asian J Trop Med Public Health 39:766-84. 2008
    ....
  12. ncbi Transmission of HIV-1 infection in sub-Saharan Africa and effect of elimination of unsafe injections
    George P Schmid
    WHO, Geneva, Switzerland
    Lancet 363:482-8. 2004
    ..Increased efforts are needed to reduce sexual transmission of HIV-1...
  13. ncbi [Male circumcision--an evidence-based preventive measure]
    Nicolai Lohse
    Ugeskr Laeger 170:2359; author reply 2360. 2008
  14. ncbi Influence of human papillomavirus type 16 (HPV-16) E2 polymorphism on quantification of HPV-16 episomal and integrated DNA in cervicovaginal lavages from women with cervical intraepithelial neoplasia
    Naoufel Azizi
    Laboratoire de Virologie Moleculaire, Centre de recherche du Centre Hospitalier de l Universite de Montreal, Montreal, Quebec, Canada
    J Gen Virol 89:1716-28. 2008
    ..24) or CIN-1 (5 of 14, P=0.50). HPV-16 E2 polymorphism was a significant factor that influenced measures of HPV-16 integrated viral load...
  15. ncbi Sex, drugs, and gender? High time for lived experience to inform action
    Catherine Hankins
    Int J Drug Policy 19:95-6. 2008
  16. ncbi Gender and the use of antiretroviral treatment in resource-constrained settings: findings from a multicenter collaboration
    Paula Braitstein
    Department of Medicine, Indiana University, Indianapolis, Indiana, USA
    J Womens Health (Larchmt) 17:47-55. 2008
    ....
  17. ncbi Polymorphism of the L1 capsid gene and persistence of human papillomavirus type 52 infection in women at high risk or infected by HIV
    Simon Gagnon
    Laboratoire de Virologie Moleculaire, Centre de Recherche and Département de Microbiologie Infectiologie, Centre Hospitalier de l Universite de Montreal, Montreal, Quebec, Canada
    J Acquir Immune Defic Syndr 44:61-5. 2007
    ..45). L1 variations are unlikely to predispose to HPV-52 persistence and thus do not help to identify women at greater risk for HSILs...
  18. ncbi AIDS in Africa
    Peter D Ghys
    Lancet 360:1425; author reply 1425. 2002
  19. ncbi Back to basics in HIV prevention: focus on exposure
    Elizabeth Pisani
    Family Health International, Bangkok, Thailand
    BMJ 326:1384-7. 2003
  20. ncbi Human papillomavirus and HIV coinfection and the risk of neoplasias of the lower genital tract: a review of recent developments
    Alex Ferenczy
    Department of Pathology, McGill University and Sir Mortimer B Davis Jewish General Hospital, Montreal, QC
    CMAJ 169:431-4. 2003
    ..In addition, we present strategies for monitoring and treating noninvasive and invasive neoplasias of the lower genital tract in HIV-positive women...
  21. ncbi Molecular analysis of human papillomavirus type 52 isolates detected in the genital tract of human immunodeficiency virus-seropositive and -seronegative women
    Joséphine Aho
    Laboratoire de Virologie Moleculaire, Centre de Recherche du Centre Hospitalier, and Département de Microbiologie et Immunologie, Université de Montréal Montréal, Canada
    J Infect Dis 188:1517-27. 2003
    ..White women were more frequently infected by the prototype strain than were women of African descent (P=.0001). The genetic diversity of HPV-52 should facilitate the investigation of the role of genomic variations in cervical disease...
  22. ncbi Achieving the WHO/UNAIDS antiretroviral treatment 3 by 5 goal: what will it cost?
    Juan Pablo Gutierrez
    Division of Health Economics and Policy, National Institute of Public Health, Cuernavaca, Mexico
    Lancet 364:63-4. 2004
    ..We estimate that between US5.1 billion dollars and US5.9 billion dollars will be needed by the end of 2005 to provide ART, support programmes, and cover country-level administrative and logistic costs for 3 by 5...
  23. ncbi Polymorphism of human papillomavirus type 31 isolates infecting the genital tract of HIV-seropositive and HIV-seronegative women at risk for HIV infection
    Simon Gagnon
    , , , , Canada
    J Med Virol 75:213-21. 2005
    ..03). Four (23.5%) of 17 women with persistent versus 6 (25.0%) of 24 women with transient infections were infected by the prototype (P=1.00). HPV-31 LCR was more polymorphic than oncogenes and was associated with ethnicity...
  24. ncbi High levels of HPV-16 DNA are associated with high-grade cervical lesions in women at risk or infected with HIV
    Julie Fontaine
    , , , , Canada
    AIDS 19:785-94. 2005
    ..007). CONCLUSION: Higher HPV-16 DNA loads are associated with cervical lesions detected by either histology or cytology. No additional information is gained by measuring integrated or episomal over total HPV-16 DNA loads...
  25. ncbi The global impact of scaling up HIV/AIDS prevention programs in low- and middle-income countries
    John Stover
    Futures Group/Constella, Glastonbury, CT 06033, USA
    Science 311:1474-6. 2006
    ..Thus, greater spending on prevention now would not only prevent more than half the new infections that would occur from 2005 to 2015 but would actually produce a net financial saving as future costs for treatment and care are averted...
  26. ncbi Complex emergencies, HIV, and substance use: no "big easy" solution
    Steffanie A Strathdee
    Department of Family and Preventive Medicine, University of California, San Diego, USA
    Subst Use Misuse 41:1637-51. 2006
  27. ncbi Continuing HIV transmission among injection drug users in Eastern Central Canada: the SurvUDI Study, 1995 to 2000
    Catherine Hankins
    Direction de la Santé Publique de Montréal Centre, Montreal, Canada
    J Acquir Immune Defic Syndr 30:514-21. 2002
    ..To document HIV prevalence/incidence trends from 1995-2000 and associated risk factors among injection drug users (IDUs) in Eastern Central Canada as an indication of harm reduction strategy effectiveness...